Integra Lifesciences Holdings (IART) Consolidated Net Income (2009 - 2026)

Integra Lifesciences Holdings (IART) has 17 years of Consolidated Net Income data on file, last reported at -$4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Consolidated Net Income rose 81.75% year-over-year to -$4.6 million; the trailing twelve-month figure through Mar 2026 stood at -$495.8 million (down 1612.31% YoY), and the FY2025 full-year result was -$516.5 million, down 7337.7% from the prior year.
• Consolidated Net Income eased to -$4.6 million in Q1 2026, from -$1.7 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $52.9 million in Q4 2022 to a low of -$484.1 million in Q2 2025.
• A 5-year average of -$16.5 million and a median of $4.2 million in 2023 frame the typical range for Consolidated Net Income.
• Across the five-year window, Consolidated Net Income plunged 3803.18% in 2025 and jumped 81.75% in 2026, its largest moves.
• Tracing IART's Consolidated Net Income over 5 years: stood at $52.9 million in 2022, then sank by 62.54% to $19.8 million in 2023, then retreated by 2.01% to $19.4 million in 2024, then slumped by 108.77% to -$1.7 million in 2025, then slumped by 170.95% to -$4.6 million in 2026.
• Business Quant data shows IART's Consolidated Net Income at -$4.6 million in Q1 2026, -$1.7 million in Q4 2025, and -$5.4 million in Q3 2025.